Imprivata Inc (IMPR) Files Form 4 Insider Selling : Christopher A Shaw Sells 12,000 Shares

Imprivata Inc (IMPR): Christopher A Shaw , SVP and General Manager of Imprivata Inc sold 12,000 shares on Jul 11, 2016. The Insider selling transaction was reported by the company on Jul 13, 2016 to the Securities and Exchange Commission. The shares were sold at $14.51 per share for a total value of $174,193.27 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 6, 2016, Jeffrey Kalowski (Chief Financial Officer) sold 10,000 shares at $12.98 per share price.On Apr 29, 2016, Omar Hussain (President and CEO) sold 18,936 shares at $12.12 per share price.Also, On Apr 19, 2016, Thomas W. Brigiotta (SVP, WW Sales and Field Ops) sold 10,000 shares at $12.80 per share price.On Mar 4, 2016, Christopher A Shaw (SVP and General Manager) sold 1,000 shares at $11.62 per share price.

Imprivata Inc: On Monday, Jul 11, 2016 heightened volatility was witnessed in Imprivata Inc which led to swings in the share price. The shares opened for trading at $14.42 and hit $14.54 on the upside , eventually ending the session at $14.37, with a gain of 0.21% or 0.03 points. The heightened volatility saw the trading volume jump to 67,468 shares. The 52-week high of the share price is $21.63 and the company has a market cap of $364 M . The 52-week low of the share price is at $9.

Imprivata Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.Imprivata Inc is Downgraded by Piper Jaffray to Neutral. Earlier the firm had a rating of Overweight on the company shares. The Rating was issued on Jul 13, 2016.

Imprivata Inc. is a provider of healthcare information technology) IT security solutions. The Company’s solutions provide authentication management access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products which consists of three offerings: authentication management enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).

Leave a Reply

Imprivata Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Imprivata Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.